Objective
* To establish the relationship between immune response to filarial parasite antigens and the length of exposure to transmission.
* To identify major antigens from the infective L3 stage of Brugia malayi, as defined by reactivity with human immune sera and T cells.
* To identify the major antigens from the microfilarial (Mf) stage, and to test for antigenic variants of these antigens.
Expected Outcome
* An understanding of stage-specific immune responses in pathology and immunity.
* Molecular data on sequence and polymorphism of Mf sheath antigens.
* Sequence and profile of immune recognition of L3 antigens.
The immunology of exposure to and infection with lymphatic filarial parasites, with respect to T cell subsets and stage-specific antigens, will be assessed. The first aspect will be the relationship between exposure to filarial transmission and the evolution of immunomodulated responses, evident in a strongly TH2 biased, TH1 down-regulated profile. Patients subject to lifelong transmission of filariasis will be compared with immigrants into the same area whose exposure is limited to only 4 or 8 years. The progression of the T cell subset bias, and the development of antigen-specific unresponsiveness seen in filariasis, will be monitored. An important question is whether this subset bias relates primarily to the adult stage, or whether other stages are similarly involved.
Secondly, prominent antigens from L3 and Mf stages will be isolated and cloned for functional analyses. The importance of such antigens in mediating protection against disease can be directly assessed using sera and T cells from the study populations; their biological role in the host-parasite relationship may also be deduced from database sequence similarities and the opportunity to discover new antigens from immature parasites through the new Filarial Genome Project.
A number of other biological questions which underpin filarial disease and its cure will also be addressed. Preliminary evidence for antigenic polymorphism in the Mf sheath antigens will be pursued, using different isolates and species of filarial parasite. The interaction between the anti-filarial drug, DEC, and Mf antigens will be studied. The role of non-CD4 T cells, which may prejudice the immune response towards the TH2 pathway from a very early stage, will be examined.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pathology
- natural sciences mathematics pure mathematics mathematical analysis functional analysis
- social sciences sociology demography human migrations
- natural sciences biological sciences genetics genomes
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
EH9 3Jr EDINBURGH
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.